Αποτελέσματα Αναζήτησης
The mean time span between COVID-19 infection and the occurrence of reactive arthritis symptoms was 22.3 ± 10.7 days. Between studies diagnosis and management of reactive arthritis were heterogeneous. Symptoms resolved within few days in all studies considered.
- Reactive arthritis occurring after COVID-19 infection: a narrative ...
Reactive arthritis is acute aseptic arthritis occurring 1 to...
- Reactive arthritis after COVID-19: a case-based review - PMC
With the focus on arthritis after SARS-CoV2 infection, which...
- Reactive arthritis following COVID-19: cause for concern
Low-quality evidence suggests that COVID-19 may trigger...
- Reactive arthritis after COVID-19: a case-based review - PubMed
The case is here reported of a 53-year-old female patient...
- Reactive arthritis occurring after COVID-19 infection: a narrative ...
15 Μαρ 2023 · Poor evidence suggests that COVID-19 could target the musculoskeletal system causing reactive arthritis at its post infectious stage. COVID-19 can act as a causative agent or as a trigger for development of reactive arthritis even without presence of antibodies of rheumatological disorders.
Reactive arthritis is acute aseptic arthritis occurring 1 to 4 weeks after a distant infection in a genetically predisposed individual. It may occur after COVID-19 infection. We summarize, in this article, the current findings of reactive arthritis following COVID-19 infection.
With the focus on arthritis after SARS-CoV2 infection, which emerges as a new pathological condition associated with COVID-19, it was aimed to examine the possible immunological mechanisms of post-COVID-19 arthritis based on the current data on SARS-CoV-2 and the known pathogenetic background of viral arthritis.
21 Φεβ 2023 · Low-quality evidence suggests that COVID-19 may trigger reactive arthritis one to four weeks after the infection. Post COVID-19 reactive arthritis resolves within a few days, and no additional treatment is required.
The patient presented 7 days after resolution of SARS- CoV- 2 infection with typical, although mild, symptoms of COVID- 19 with severe swelling and pain in the left ankle joint and forefoot. Based on the overall picture, ReA appears to be the most likely cause of the patient’s symptoms.
The case is here reported of a 53-year-old female patient with acute monoarthritis after SARS-CoV-2 infection, who responded adequately to 150 mg/day diclofenac treatment, and the available case reports are comprehensively reviewed.